| A | B | C | |
|---|---|---|---|
| 1 | Main | ||
| 2 | Generic Name | abiraterone | |
| 3 | Mechanism | ||
| 4 | Clinical Trials | ||
| 5 | Phase III in asymptomatic or mildly symptomatic mCRPC n=1000, began April 2009 | ||
| 6 | Prednisone/Prednisolone+-abiraterone | ||
| 7 | |||
| 8 | Phase III in 2L CRPC n=1158 began April 2008 | ||
| 9 | Completed enrollment, overall survival primary endpoint |